BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38556858)

  • 1. MicroRNA expression as a prognostic biomarker of tongue squamous cell carcinoma (TSCC): a systematic review and meta-analysis.
    Sun Y; Li Y; Zhou W; Liu Z
    BMC Oral Health; 2024 Mar; 24(1):406. PubMed ID: 38556858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-27a promotes tumorigenesis in tongue squamous cell carcinoma by enhancing proliferation, migration and suppressing apoptosis.
    Chen H; Dong Z; Chen Y; Cui Y; Song P; Yang K
    Eur Arch Otorhinolaryngol; 2021 Nov; 278(11):4557-4567. PubMed ID: 33912994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of miR-139-5p as a saliva biomarker for tongue squamous cell carcinoma: a pilot study.
    Duz MB; Karatas OF; Guzel E; Turgut NF; Yilmaz M; Creighton CJ; Ozen M
    Cell Oncol (Dordr); 2016 Apr; 39(2):187-93. PubMed ID: 26650483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA expression and its implications for diagnosis and therapy of tongue squamous cell carcinoma.
    Yu X; Li Z
    J Cell Mol Med; 2016 Jan; 20(1):10-6. PubMed ID: 26498914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-137 suppresses tongue squamous carcinoma cell proliferation, migration and invasion.
    Sun L; Liang J; Wang Q; Li Z; Du Y; Xu X
    Cell Prolif; 2016 Oct; 49(5):628-35. PubMed ID: 27571935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationships between microRNA expressions and prognosis in patients with tongue squamous cell carcinoma and the mechanisms microRNA regulating tongue squamous cell carcinoma biological behavior].
    Jia LF; Gan YH; Yu GY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):5-9. PubMed ID: 26885901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNome-transcriptome analysis unveils the key regulatory pathways involved in the tumorigenesis of tongue squamous cell carcinoma.
    Gupta P; Chattopadhyay T; Mallick B
    Brief Funct Genomics; 2022 Nov; 21(6):466-477. PubMed ID: 36255066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LUCAT1 as an oncogene in tongue squamous cell carcinoma by targeting miR-375 expression.
    Zhang K; Wang Q; Zhong B; Gong Z
    J Cell Mol Med; 2021 May; 25(10):4543-4550. PubMed ID: 33787082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin-dependent kinase 5 promotes the growth of tongue squamous cell carcinoma through the microRNA 513c-5p/cell division cycle 25B pathway and is associated with a poor prognosis.
    Li Y; Yao F; Jiao Z; Su X; Wu T; Peng J; Yang Z; Chen W; Yang A
    Cancer; 2022 May; 128(9):1775-1786. PubMed ID: 35143052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-802 plays a tumour suppressive role in tongue squamous cell carcinoma through directly targeting MAP2K4.
    Wu X; Gong Z; Sun L; Ma L; Wang Q
    Cell Prolif; 2017 Jun; 50(3):. PubMed ID: 28319306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of PTEN Expression Is Associated With High MicroRNA 24 Level and Poor Prognosis in Patients With Tongue Squamous Cell Carcinoma.
    Zhao J; Chi J; Gao M; Zhi J; Li Y; Zheng X
    J Oral Maxillofac Surg; 2017 Jul; 75(7):1449.e1-1449.e8. PubMed ID: 28413152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CBX3 promotes tumor proliferation by regulating G1/S phase via p21 downregulation and associates with poor prognosis in tongue squamous cell carcinoma.
    Zhang H; Chen W; Fu X; Su X; Yang A
    Gene; 2018 May; 654():49-56. PubMed ID: 29462646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental-Cadherin, a biomarker for local immune status and poor prognosis among patients with tongue squamous cell carcinoma.
    Wang H; Yu T; Mao L
    Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3597-3609. PubMed ID: 34825969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulation of manganese superoxide dismutase (SOD2) expression and lymph node metastasis in tongue squamous cell carcinoma.
    Liu X; Wang A; Lo Muzio L; Kolokythas A; Sheng S; Rubini C; Ye H; Shi F; Yu T; Crowe DL; Zhou X
    BMC Cancer; 2010 Jul; 10():365. PubMed ID: 20618948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis.
    Wei Z; Wang Y; Li Z; Yuan C; Zhang W; Wang D; Ye J; Jiang H; Wu Y; Cheng J
    J Oral Pathol Med; 2013 Nov; 42(10):747-54. PubMed ID: 23551691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRBP-1 over-expression is associated with poor prognosis in tongue squamous cell carcinoma.
    Chen Y; Tian T; Mao MJ; Deng WY; Li H
    BMC Cancer; 2018 May; 18(1):514. PubMed ID: 29720147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic implications of micoRNA miR-195 expression in human tongue squamous cell carcinoma.
    Jia LF; Wei SB; Gong K; Gan YH; Yu GY
    PLoS One; 2013; 8(2):e56634. PubMed ID: 23451060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High SOX8 expression promotes tumor growth and predicts poor prognosis through GOLPH3 signaling in tongue squamous cell carcinoma.
    Chen S; Li H; Li X; Chen W; Zhang X; Yang Z; Chen Z; Chen J; Zhang Y; Shi D; Song M
    Cancer Med; 2020 Jun; 9(12):4274-4289. PubMed ID: 32307911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FSCN1 is an effective marker of poor prognosis and a potential therapeutic target in human tongue squamous cell carcinoma.
    Chen Y; Tian T; Li ZY; Wang CY; Deng R; Deng WY; Yang AK; Chen YF; Li H
    Cell Death Dis; 2019 May; 10(5):356. PubMed ID: 31043585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Establishment and verification of a prognostic nomogram for survival of tongue squamous cell carcinoma patients who underwent cervical dissection].
    Su J; Wang X; Sun Z
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 56(1):120-130. PubMed ID: 38318906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.